Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Cancer risk of glucagon-like peptide-1 receptor agonists for obesity: comparison with bariatric surgery and other weight-loss drugs
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2026;30(9):102497
Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters
Endocrine journal, 2026
Real-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study
Drug design, development and therapy, 2026;20:604247
Resolution of anhedonia-like symptoms in patients treated for obesity with tirzepatide: A three-case series
Obesity pillars, 2026;19:100302
Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review
Acta diabetologica, 2026
Revision Medialization Thyroplasty for Glottic Insufficiency Amid Rapid Weight Loss on Semaglutide
The Laryngoscope, 2026
Comment on ‘Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan’
Diabetes, obesity & metabolism, 2026
Safety Profile of Tirzepatide in Real-World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database
Diabetes, obesity & metabolism, 2026
Treatment Patterns and Experienced Effects of Semaglutide for Weight Management Among Adult Users in Denmark: A Community Pharmacy-Based Cross-Sectional Survey
Diabetes, obesity & metabolism, 2026
Tirzepatide, cardiovascular outcomes and mortality in obesity and diabetes: a systematic review and meta-analysis
Diabetes research and clinical practice, 2026;:113431
GLP-1 Receptor Agonists and Fertility: What Is Known So Far?
JBRA assisted reproduction, 2026
Amylin-based obesity therapy: a meta-analysis of Cagrilintide and CagriSema versus placebo
Annals of medicine and surgery (2012), 2026;88(8):5317-5326
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access
Obesity (Silver Spring, Md.), 2026
Effectiveness and Safety of Combined Semaglutide and Dapagliflozin Therapy in Type 2 Diabetes: A Retrospective Cohort Study
Cureus, 2026;18(7):e112523
TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications
Handbook of experimental pharmacology, 2026
Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice
Molecular brain, 2026
The Periprocedural Safety of Continued GLP-1 Receptor Agonist Prior to Cardiac Catheterization
The American journal of cardiology, 2026
Pharmacologic Treatment for Obstructive Sleep Apnea in Older Adults
Drugs & aging, 2026
Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026
Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial
Current medical research and opinion, 2026;:1-13